Sumatriptan

What sumatriptan is, in plain English

Sumatriptan is a prescription triptan used to stop a migraine attack once it has already started, and the injection form is also approved for cluster headache attacks in adults. It narrows widened blood vessels in the head and quiets migraine pain signals. It does not prevent future attacks.

The molecule has carried official US labeling for decades, so this page rests on an approved label rather than on marketing copy. It is prescription only. That is not a formality: the label asks a clinician to confirm a migraine or cluster headache diagnosis first, and to weigh your heart and stroke risk before writing the first prescription.

The drug class matters more than the brand. Sumatriptan is a selective serotonin 5-HT1B/1D receptor agonist, the group patients and clinicians call triptans. Other members include rizatriptan, zolmitriptan, naratriptan, eletriptan, almotriptan and frovatriptan. They share a family resemblance in how they work and in the cautions attached to them, though they differ in how fast they act and how long they stay in the body.

It is not an opioid, not an NSAID like ibuprofen, and not acetaminophen. So it is not a general purpose painkiller. It will not touch a sprained ankle or a toothache. It targets the biology of a migraine attack, which is why it can work well for a migraine and do nothing at all for another kind of pain.

Who tends to be prescribed it? Adults with a confirmed migraine pattern whose attacks are moderate to severe, or whose milder attacks do not respond to over the counter options. It is also used by adults with cluster headache attacks, where the injection is the labeled form. People with significant cardiovascular disease are usually steered elsewhere, and that is one of the most important boundaries on the label. You can compare it against other prescription options on our Prescription Medication Guides index.

How it works once an attack starts

During a migraine, blood vessels around the brain and the coverings of the brain widen, and the trigeminal nerve system releases inflammatory chemicals, including a peptide called CGRP. The result is throbbing pain, nausea and sensitivity to light and sound.

Sumatriptan attaches to serotonin 5-HT1B and 5-HT1D receptors. Through the 1B receptor it constricts those dilated blood vessels. Through the 1D receptor it reduces the release of inflammatory peptides from nerve endings and dampens pain messages travelling toward the brainstem. A useful summary of this mechanism is available in a National Library of Medicine clinical reference on sumatriptan.

Two practical points follow from that mechanism. First, timing matters. Triptans generally work better when taken early in an attack, before pain becomes severe, which is why many clinicians tell patients to carry a dose with them. Second, the same vessel narrowing that helps a migraine can also narrow vessels elsewhere in the body. That single fact explains nearly every serious warning on the label, from chest symptoms to rare bowel and circulation problems.

It is worth being clear about what it does not do. It does not sedate you, it does not reduce headache frequency over time, and it is not designed for daily use. Preventive migraine care is a separate track that may involve daily tablets, monthly injections or other approaches, and that conversation belongs with a clinician who knows your attack pattern.

What US labeling approves it to treat

Approved uses in adults are narrow and specific. The labeling covers the acute treatment of migraine, with or without aura, meaning treatment of an attack in progress. The subcutaneous injection is additionally approved for the acute treatment of cluster headache attacks in adults. Oral tablets are not approved for cluster headache.

The label also states its own limits plainly. Use it only when a clear diagnosis of migraine or cluster headache has been established. If a first attack treated with the medicine brings no response, the diagnosis itself should be reconsidered rather than assuming the next attack will go better. And it is not indicated for preventing attacks of either kind.

Some rarer headache patterns sit outside what triptan labeling supports, including hemiplegic migraine and migraine with brainstem aura, sometimes called basilar migraine. Those presentations need a clinician’s assessment rather than a self-directed trial. For patient facing background on migraine itself, the National Institute of Neurological Disorders and Stroke migraine overview is a reasonable starting point.

Doses, maximum amounts in 24 hours and minimum waiting time between doses all differ by form, and every form has its own ceiling. This page will not put numbers on that, because the right numbers are the ones printed on your prescription and in the labeling for the exact product you were given. Ask the prescriber what your daily limit is and how many days per month you can reasonably use it.

Side effects, and how long they usually last

Most side effects are mild, short lived and strange rather than dangerous. Patients often describe a wave of odd sensations shortly after a dose. That cluster is common enough that clinicians nickname it triptan sensations.

• Tingling, prickling or numbness, often in the head, face, hands or feet
• Feelings of warmth, heat or flushing
• A heavy, tight or pressured feeling in the chest, neck, throat or jaw
• Dizziness, drowsiness or a general sense of weakness
• Nausea or vomiting, which can also be part of the migraine itself
• Injection site pain, redness or stinging with the shot forms
• A bitter taste, nasal irritation or a burning sensation in the nose with nasal forms

How long do they last? Usually not long. These effects tend to appear within minutes to about an hour of a dose and fade over the following one to two hours as blood levels fall. Drowsiness can linger a little longer. If an effect persists for many hours, or returns worse with each dose, that is worth reporting rather than tolerating. Patient level summaries of common and serious effects are maintained on the MedlinePlus drug information page for sumatriptan and by the Mayo Clinic oral route side effect listing.

Serious reactions are uncommon but real, and they are the reason this medicine is prescription only. They include heart attack and myocardial ischemia, dangerous heart rhythms, Prinzmetal angina, stroke and bleeding in the brain, reduced blood flow to the intestines with severe abdominal pain and bloody diarrhea, and Raynaud type changes where fingers or toes turn pale, blue and painfully cold. Sudden vision loss, seizures and severe allergic reactions have also been reported.

Chest and throat tightness deserves its own note, because it frightens people. Labeling says these sensations are generally not caused by blocked heart arteries, but it also says patients at high cardiac risk should be evaluated rather than reassured. That is the honest position: usually benign, occasionally not, and not something to self-diagnose during an attack.

One more effect is easy to miss because it looks like the disease. Using any acute headache medicine too often can drive medication overuse headache, a pattern of more frequent, more stubborn headaches. If you find yourself reaching for a dose on many days each month, the treatment plan needs revisiting, not more doses.

Who should not take it, plus the warnings that matter

Contraindications on the label are unusually concrete for a headache medicine. The following groups are told not to use it at all, according to the manufacturer prescribing information for sumatriptan tablets:

• People with ischemic coronary artery disease, or a history of heart attack or Prinzmetal angina
• People with Wolff Parkinson White syndrome or other arrhythmias linked to accessory conduction pathways
• People with a history of stroke, transient ischemic attack or hemiplegic or brainstem aura migraine
• People with peripheral vascular disease or ischemic bowel disease
• People with uncontrolled high blood pressure
• People with severe liver impairment, for the oral forms
• People who have taken a monoamine oxidase A inhibitor in the past two weeks
• People with a known allergy to sumatriptan

Beyond those absolutes, the label asks for a cardiac evaluation before the first dose in anyone with several cardiovascular risk factors, such as older age, smoking, diabetes, high cholesterol, obesity, a strong family history or postmenopausal status. That screening step is part of why patients sometimes feel the prescribing process is stricter than they expected.

Blood pressure is one of the checkable items on that list, and a single reading taken in a hurry is a poor guide. Averaging several readings across a few days gives a clinician something more useful to work with.

If any serious event occurs, the labeling response is not to reduce the dose but to stop the drug and reassess. That applies to arrhythmias, to stroke or brain bleeding, and to signs of poor blood flow in the gut or limbs.

Drug interactions worth flagging

Interactions cluster around serotonin and around other vasoconstrictors. Three rules do most of the work.

First, do not stack triptans. Taking another triptan within 24 hours can add up vessel narrowing effects. Second, keep ergot type medicines, such as ergotamine or dihydroergotamine, separated by at least 24 hours in either direction, for the same reason. Third, monoamine oxidase A inhibitors, including phenelzine and tranylcypromine, are off limits within two weeks because they slow the breakdown of the drug.

Serotonin syndrome is the interaction patients ask about most. Combining a triptan with an SSRI or SNRI antidepressant, and in some cases with other serotonergic medicines such as certain migraine preventives, tramadol or St John’s wort, can rarely produce agitation, confusion, fever, a racing heart, sweating, muscle twitching, tremor or diarrhea. The FDA drug safety and availability hub collects the agency’s communications on this class of risk. Many people take both types of medicine safely under supervision, so the practical step is disclosure, not automatic avoidance.

Tell whoever prescribes it about every prescription, over the counter product, supplement and herbal remedy you use, including anything for depression, anxiety, weight, pain or sleep. Also mention how often you already use acute headache treatments, since that shapes the plan more than most patients expect.

Pregnancy, breastfeeding and other special situations

Pregnancy is a common question and the honest answer is qualified. Labeling notes there are no adequate and well controlled studies in pregnant women, and observational data have not established a clear pattern of harm, but they cannot rule out risk either. Migraine patterns themselves often change during pregnancy. This is a decision to make with an obstetric clinician who can weigh attack severity against alternatives, not a decision to make from a search result.

Small amounts pass into breast milk, and labeling discusses limiting infant exposure. Again, that is a conversation, not a rule you can apply alone.

Older adults may have more cardiovascular risk factors, and liver or kidney problems change how the body handles the drug, so form and dose choices may differ. Pediatric approval varies by product and several forms are labeled for adults only. If the patient is a teenager, ask specifically which product is approved for their age.

Forms, brand names and generic versions

Sumatriptan comes in more forms than almost any other migraine medicine, and the form is often the whole decision. If vomiting starts early in your attacks, a tablet may not stay down. If attacks escalate within minutes, an injection may make sense.

Brand names you may see include Imitrex for tablets, nasal spray and injection, along with newer branded nasal and injectable products and a combination tablet that pairs the triptan with naproxen. Generic versions of most forms are widely marketed.

Is generic different from the brand? The active molecule is identical, and FDA approved generics must demonstrate bioequivalence to the reference product. Inactive ingredients, tablet appearance and, importantly, device design can differ. With nasal sprays and autoinjectors, the device is part of the experience, so some patients do notice a change when a pharmacy switches manufacturers. If that happens to you, say so; it is a legitimate thing to raise. Approval details for specific products can be looked up through the Drugs at FDA product database.

Nasal spray versus tablets is the comparison patients search most. In broad terms, nasal delivery bypasses a nauseated stomach and some patients prefer it for fast rising attacks, while tablets are simpler, more familiar and usually cheaper as generics. Neither is universally better, and labeling does not support ranking them for everyone.

What it costs without insurance

Cost splits along two tracks that should never be blended: what you pay as a self-pay patient, and what a plan charges once it is involved. On the self-pay side, generic tablets are among the older, well established generics, and cash prices vary widely by pharmacy, quantity dispensed and form. Injections and branded nasal products generally sit well above generic tablets.

Across telehealth programs the directory tracks, the lowest recurring self-pay price starts at a month, with a tracked median of . Those figures cover the monthly program price a new patient can start on, and advertised prices change often, so treat any number as a snapshot rather than a promise. What moves the figure is fairly predictable: brand versus generic, the form and device, how many doses are dispensed at a time, whether a consultation or membership fee is bundled in, and whether an introductory rate steps up at renewal.

Because acute migraine medicine is bought in bursts rather than daily, the yearly picture is often more informative than one month.

On the insurance track, a plan may place the generic on a low tier while limiting how many doses are covered per month, a quantity limit that surprises patients who have frequent attacks. Prior authorization or step therapy can also apply, particularly for branded nasal and injectable products. Never assume coverage; verify the specific product and quantity with your own plan, since terms differ by plan and by state. For policy level context on how drug benefits and out of pocket costs are structured, KFF publishes ongoing prescription cost research. If you want to see how self-pay comparisons are laid out before committing anywhere, our Free Savings Report shows the format, and the Free Health Calculators page holds the cost tools in one place.

How telehealth programs handle acute migraine

Prescribing a triptan online is routine, but programs differ more than their landing pages suggest. The differences worth comparing are practical.

1. Scope of care. Some programs treat acute attacks only. Others also manage preventive treatment, which matters if you have attacks most weeks.
2. Screening depth. Because of the cardiovascular contraindications, ask whether intake covers heart history, blood pressure and stroke risk, and whether a clinician reviews it or a form simply flags it.
3. Quantity and refills. Ask how many doses arrive per fill, how refills are authorized and what happens when you run short mid month.
4. Payment route. Some programs are cash pay only; others can bill certain plans, which is not the same as your plan covering the medicine.
5. Pharmacy and form. Ask which forms the program can supply, since not every program offers nasal or injectable options.
6. State licensure. Telemedicine prescribing rules and clinician licensing are state specific, so availability can differ by where you live.
7. Follow up. Ask who reviews your response after the first few attacks, and how a switch to another triptan is handled if this one does not work.

Patients on this site review the programs, not the molecule, and those reviews are moderated before publication. Ratings sit alongside our Scoring Methodology, which sets out the dimensions behind each provider score. You can browse programs in the Telehealth Provider Directory, and our Telehealth Analysis Articles dig into how pricing models and follow up care compare across categories.

Questions to ask, and when to get urgent help

Bring a short list to the visit. Useful questions include: does my history rule this out on cardiovascular grounds; which form fits my attack pattern and nausea; how early should I take it; what is my limit in 24 hours and per month; what should I do if the headache returns later the same day; how will we know if it is not working; what are the alternatives if it fails or the side effects bother me; and should we be discussing prevention as well as rescue treatment.

Keep a simple attack log for a few weeks: date, time of onset, what you took, how long relief took and whether the headache came back. That record answers most follow up questions faster than memory does.

Some symptoms mean stop and seek emergency care rather than wait. Call 911 or go to an emergency department for chest pain, pressure or tightness that is severe or spreads to the arm, neck or jaw, especially with shortness of breath or sweating; a sudden severe headache unlike any you have had; weakness or numbness on one side, drooping face, slurred speech or sudden vision loss; severe abdominal pai